Scarica l'app Stockscreener
13.87
0.57%
-0.08
Dopo l'orario di chiusura:
13.90
0.03
+0.22%
Mediwound Ltd Borsa (MDWD) Ultime notizie
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEBITDA Margin Trends - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideFinancial Data - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
MediWound (MDWD) Insider Trading Activity 2026 - MarketBeat
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus
Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - Moomoo
Oppenheimer Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely? - Yahoo Finance
MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $36 - Moomoo
MediWound: Q1 Earnings Snapshot - AOL.com
MediWound Q1 2026 Earnings Call Transcript - MarketBeat
MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives - simplywall.st
Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus
Q1 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue Challenges - GuruFocus
Oppenheimer lowers MediWound stock price target to $32 on revenue miss - Investing.com UK
Oppenheimer lowers MediWound stock price target to $32 on revenue miss By Investing.com - Investing.com Australia
MediWound Q1 2026 earnings preview - MSN
MediWound (MDWD) reports Q1 2026 results, reaffirms guidance - grafa.com
MediWound Q1 Earnings Call Highlights - sharewise.com
MediWound (MDWD) Reports Q1 Revenue Below Expectations - GuruFocus
MediWound Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Mediwound Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MEDIWOUND ($MDWD) Releases Q1 2026 Earnings - Quiver Quantitative
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid - TipRanks
MDWD: Q1 revenue fell but margin improved; EscharEx and NexoBrid progress support 2026 outlook - TradingView
MediWound (NASDAQ: MDWD) Q1 2026 revenue drops as 2026 guidance held - Stock Titan
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):